The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy

Journal of Surgical Oncology

Volumn 104, Issue 6, 2011, Pages 585-591

  Kim, Dae Hoon ^a   Oh, Seung Jong ^a   Oh, Cheong Ah ^a   Choi, Min Gew ^a   Noh, Jae Hyung ^a   Sohn, Tae Sung ^a   Bae, Jae Moon ^a   Kim, Sung ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

CA 19 9; CA 72 4; CEA; gastric cancer

Indexed keywords

CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; DISEASE SEVERITY; EARLY CANCER; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

ADENOCARCINOMA; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE CARE; PROGNOSIS; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053600194     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21919     Document Type: Article

References (28)

1. Jung KW, Won YJ, Park S, et al.: Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci 2009; 24: 995-1003.
2. Kim JP, Kim YW, Yang HK, et al.: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg 1994; 18: 872-877 discussion 877-878.
3. Siewert JR, Bottcher K, Stein HJ, et al.: Relevant prognostic factors in gastric cancer: ten-year Results: of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-461. (Pubitemid 30194389)
4. Maruyama K,: The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analyses. Scand J Gastroenterol Suppl 1987; 22: 63-68. (Pubitemid 17112517)
5. Reiter W, Stieber P, Reuter C, et al.: Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Anticancer Res 1997; 17: 2903-2906. (Pubitemid 27434816)
6. Marrelli D, Roviello F, De Stefano A, et al.: Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57: 55-62. (Pubitemid 29308672)
7. Aloe S, D'Alessandro R, Spila A, et al.: Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer. Int J Biol Markers 2003; 18: 21-27. (Pubitemid 37304097)
8. Ucar E, Semerci E, Ustun H, et al.: Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther 2008; 25: 1075-1084.
9. Nakane Y, Okamura S, Akehira K, et al.: Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994; 73: 2703-2708. (Pubitemid 24166254)
10. Edge SB, Byrd DR, Compton CC, et al.: AJCC cancer staging manual, 7th edition. New York: Springer; 2010. 117-121.
11. Fletcher RH,: Carcinoembryonic antigen. Ann Intern Med 1986; 104: 66-73. (Pubitemid 16182780)
12. Lamerz R,: Role of tumour markers, cytogenetics. Ann Oncol 1999; 10 (Suppl 4): 145-149.
13. Johnson VG, Schlom J, Paterson AJ, et al.: Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72. 3. Cancer Res 1986; 46: 850-857. (Pubitemid 16145448)
14. Muraro R, Kuroki M, Wunderlich D, et al.: Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Cancer Res 1988; 48: 4588-4596.
15. Safi F, Kuhns V, Beger HG,: Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer. Int J Biol Markers 1995; 10: 100-106.
16. Takahashi Y, Takeuchi T, Sakamoto J, et al.: The usefulness of CEA and/or CA 19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 2003; 6: 142-145. (Pubitemid 37221564)
17. Hur H, Song KY, Park CH, et al.: Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. Ann Surg Oncol 2010; 17: 54-64.
18. Kajitani T,: The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981; 11: 127-139. (Pubitemid 11080134)
19. Kodera Y, Ito S, Yamamura Y, et al.: Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol 2003; 10: 898-902. (Pubitemid 40486854)
20. Bohner H, Zimmer T, Hopfenmuller W, et al.: Detection and prognosis of recurrent gastric cancer-is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology 2000; 47: 1489-1494.
21. Whiting J, Sano T, Saka M, et al.: Follow-up of gastric cancer: a review. Gastric Cancer 2006; 9: 74-81. (Pubitemid 43890702)
22. Guadagni F, Roselli M, Amato T, et al.: CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res 1992; 52: 1222-1227.
23. Heptner G, Domschke S, Domschke W,: Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. Scand J Gastroenterol 1989; 24: 745-750. (Pubitemid 19211668)
24. Mattar R, Alves de Andrade CR, DiFavero GM, et al.: Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Rev Hosp Clin Fac Med Sao Paulo 2002; 57: 89-92.
25. Sakamoto J, Nakazato H, Teramukai S, et al.: Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan. Surg Oncol 1996; 5: 133-139. (Pubitemid 26385514)
26. Gaspar MJ, Arribas I, Coca MC, et al.: Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 2001; 22: 318-322. (Pubitemid 32823950)
27. Marrelli D, Pinto E, De Stefano A, et al.: Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg 2001; 181: 16-19. (Pubitemid 32209115)
28. Ohtsuka T, Sato S, Kitajima Y, et al.: False-positive findings for tumor markers after curative gastrectomy for gastric cancer. Dig Dis Sci 2008; 53: 73-79. (Pubitemid 350265652)